BUSINESS
Taisho to Develop Overseas Biz in Asia and Europe through BMS’s Consumer Unit Buyout
Taisho Pharmaceutical Holdings plans to expand its overseas business by focusing on Asia and Europe, said its director Ken Uehara in a hastily called conference call on December 20, on the heels of the previous day’s announcement of its purchase of Bristol-Myers…
To read the full story
Related Article
- Taisho Completes US$1.5 Billion Acquisition of Bristol-Myers’ OTC Unit
July 3, 2019
- Taisho to Acquire Bristol-Myers’s Consumer Health Unit
December 20, 2018
BUSINESS
- Takeda CEO Says Orzeyful Could Redefine NT1 Standard of Care
July 31, 2026
- Pfizer Seeks Pediatric Expansion for Hympavzi in Japan
July 31, 2026
- Nippon Shinyaku Exercises Option for AB2 Bio’s Tadekinig Alfa in US
July 31, 2026
- Alfresa Takes Stake in Ember to Bolster Pharma Cold Chain in Japan
July 31, 2026
- Sanwa Kagaku Says Kumamoto Plant Remains Shut, Drug Supplies Stable
July 31, 2026
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…





